Lucid Diagnostics Inc.
LUCD
$1.26
-$0.02-1.56%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -45.53M | -44.82M | -46.66M | -47.03M | -52.67M |
| Total Depreciation and Amortization | 1.17M | 1.57M | 1.98M | 2.39M | 2.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.65M | 4.58M | 6.76M | 6.69M | 11.68M |
| Change in Net Operating Assets | -4.43M | -5.59M | -4.94M | -351.00K | 5.68M |
| Cash from Operations | -44.14M | -44.25M | -42.85M | -38.31M | -32.82M |
| Capital Expenditure | -296.00K | -212.00K | -226.00K | -241.00K | -221.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -350.00K | -350.00K | -- | -- | -- |
| Cash from Investing | -646.00K | -562.00K | -226.00K | -241.00K | -221.00K |
| Total Debt Issued | 21.62M | 0.00 | 0.00 | 0.00 | 10.00M |
| Total Debt Repaid | -3.62M | -- | -- | -- | -- |
| Issuance of Common Stock | 451.00K | 451.00K | 632.00K | 632.00K | 835.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 29.80M | 34.80M | 34.80M | 23.17M | 18.63M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 48.25M | 35.25M | 35.43M | 23.80M | 29.46M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.46M | -9.56M | -7.65M | -14.75M | -3.58M |